The novel approach of the medication represents a exciting advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide120692.aioblogs.com/94804406/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment